LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis
Authors
Keywords
-
Journal
Frontiers in Bioengineering and Biotechnology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-18
DOI
10.3389/fbioe.2020.00054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1
- (2019) Junsheng Gu et al. Cancer Cell International
- Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma
- (2019) Hongyan Li et al. Cancer Management and Research
- lncRNA PSTAR Promotes p53 Signaling by Inhibiting hnRNP K deSUMOylation and Suppresses Hepatocellular Carcinoma
- (2019) Geng Qin et al. HEPATOLOGY
- Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR‐199a‐3p/mTOR axis
- (2019) Yongbiao Ma et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma
- (2018) Fangfang Tao et al. FASEB JOURNAL
- LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer
- (2018) Junfeng Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- BET bromodomain proteins regulate enhancer function during adipogenesis
- (2018) Jonathan D. Brown et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long non-coding RNA HOTAIR promotes osteoarthritis progression via miR-17-5p/FUT2/β-catenin axis
- (2018) Jialei Hu et al. Cell Death & Disease
- Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
- (2018) Chuan Xing Wu et al. Theranostics
- Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer
- (2018) Hui Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis
- (2017) Yufeng Wang et al. Molecular Cancer
- Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
- (2016) Wookyeom Yang et al. Oncotarget
- High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
- (2015) Wen-Wei Sung et al. BMC CANCER
- Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma
- (2015) Jian Zhang et al. PLoS One
- p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells
- (2014) Eleonora Da Pozzo et al. ACS Chemical Neuroscience
- MDM2-p53 Pathway in Hepatocellular Carcinoma
- (2014) X. Meng et al. CANCER RESEARCH
- Earlier presentation and application of curative treatments in hepatocellular carcinoma
- (2014) Susanna V. Ulahannan et al. HEPATOLOGY
- CCNB1 is a prognostic biomarker for ER+ breast cancer
- (2014) Kun Ding et al. MEDICAL HYPOTHESES
- Physiological roles of long noncoding RNAs: insight from knockout mice
- (2014) Lingjie Li et al. TRENDS IN CELL BIOLOGY
- Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients
- (2013) J M Willder et al. BRITISH JOURNAL OF CANCER
- Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621
- (2010) Fabienne Danhier et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells
- (2010) N N Kreis et al. ONCOGENE
- Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort
- (2009) E. Niméus-Malmström et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now